Patients with head or neck cancer should be treated at specialist centres
BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7477.1257 (Published 25 November 2004) Cite this as: BMJ 2004;329:1257- Madeleine Brettingham
- London
The National Institute for Clinical Excellence (NICE) has issued guidelines on the treatment of patients with rare cancers of the head and neck. The guidelines, based on research conducted by the Centre for Reviews and Dissemination, advise that treatment should be centred at specialised cancer centres serving populations of over a million, where multidisciplinary teams will be responsible for all stages of the treatment process, including diagnosis and rehabilitation.
Head and neck cancers are not common and encompasses a range of conditions located at some 30 sites around the head and neck. Some, …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.